1.31
price down icon0.76%   -0.01
after-market Handel nachbörslich: 1.36 0.05 +3.82%
loading
Schlusskurs vom Vortag:
$1.32
Offen:
$1.33
24-Stunden-Volumen:
38,561
Relative Volume:
0.39
Marktkapitalisierung:
$69.97M
Einnahmen:
$9.16M
Nettoeinkommen (Verlust:
$-68.17M
KGV:
-0.8037
EPS:
-1.63
Netto-Cashflow:
$-80.16M
1W Leistung:
-2.24%
1M Leistung:
+2.34%
6M Leistung:
-20.61%
1J Leistung:
-19.63%
1-Tages-Spanne:
Value
$1.31
$1.3547
1-Wochen-Bereich:
Value
$1.31
$1.365
52-Wochen-Spanne:
Value
$0.9707
$1.94

Ikena Oncology Inc Stock (IKNA) Company Profile

Name
Firmenname
Ikena Oncology Inc
Name
Telefon
857-343-8292
Name
Adresse
50 NORTHERN AVE., BOSTON
Name
Mitarbeiter
9
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
IKNA's Discussions on Twitter

Vergleichen Sie IKNA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IKNA
Ikena Oncology Inc
1.31 69.97M 9.16M -68.17M -80.16M -1.63
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Ikena Oncology Inc Stock (IKNA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-05-29 Herabstufung Wedbush Outperform → Neutral
2023-09-22 Eingeleitet Wedbush Outperform
2023-05-04 Fortgesetzt H.C. Wainwright Buy
2021-12-23 Eingeleitet H.C. Wainwright Buy
2021-05-05 Fortgesetzt Credit Suisse Outperform
2021-04-26 Fortgesetzt Credit Suisse Outperform
2021-04-20 Eingeleitet Credit Suisse Outperform
2021-04-20 Eingeleitet Jefferies Buy
2021-04-20 Eingeleitet William Blair Outperform
Alle ansehen

Ikena Oncology Inc Aktie (IKNA) Neueste Nachrichten

pulisher
Jun 13, 2025

Two Sigma Investments LP Sells 55,935 Shares of Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World

Jun 13, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Acquires Shares of 43,640 Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Millennium Management LLC Trims Stake in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

Citadel Advisors LLC Lowers Position in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Two Sigma Advisers LP Has $258,000 Stock Holdings in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World

Jun 07, 2025
pulisher
Jun 04, 2025

Ikena Oncology, Inc. (NASDAQ:IKNA) Shares Bought by Northern Trust Corp - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

BNP Paribas Financial Markets Acquires New Position in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World

Jun 02, 2025
pulisher
May 27, 2025

Ikena Oncology Reports Q1 Loss Amid Merger Plans - TipRanks

May 27, 2025
pulisher
May 12, 2025

Ikena Oncology Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 08, 2025

Ikena Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Ikena Oncology, Inc. SEC 10-Q Report - TradingView

May 08, 2025
pulisher
May 04, 2025

Renaissance Technologies LLC Sells 70,400 Shares of Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World

May 04, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Purchases 56,936 Shares of Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World

May 03, 2025
pulisher
Apr 21, 2025

Marquis Who's Who Honors Wilmin P. Bartolini for Expertise in Pharmaceutical Consulting - 24-7 Press Release Newswire

Apr 21, 2025
pulisher
Apr 12, 2025

Prudential Financial Inc. Trims Holdings in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World

Apr 12, 2025
pulisher
Apr 09, 2025

Ikena Oncology stock hits 52-week low at $0.98 amid market challenges - Investing.com Canada

Apr 09, 2025
pulisher
Apr 09, 2025

Ikena Oncology stock hits 52-week low at $0.98 amid market challenges By Investing.com - Investing.com South Africa

Apr 09, 2025
pulisher
Apr 01, 2025

Ikena Oncology stock hits 52-week low at $1.21 amid market challenges - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Ikena Oncology stock hits 52-week low at $1.21 amid market challenges By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Mar 18, 2025

Ikena Oncology Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares - Business Wire

Mar 18, 2025
pulisher
Mar 13, 2025

Ikena Oncology: Investor Caution as Dividend Payments Remain Unlikely - TipRanks

Mar 13, 2025
pulisher
Mar 10, 2025

Ikena Oncology Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 10, 2025
pulisher
Mar 07, 2025

Ikena Oncology Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView

Mar 07, 2025
pulisher
Mar 06, 2025

Ikena Oncology, Inc. SEC 10-K Report - TradingView

Mar 06, 2025
pulisher
Feb 19, 2025

Short Interest in Ikena Oncology, Inc. (NASDAQ:IKNA) Decreases By 11.8% - MarketBeat

Feb 19, 2025
pulisher
Feb 14, 2025

Discovering February 2025's Promising Penny Stocks On US Exchanges - Simply Wall St

Feb 14, 2025
pulisher
Feb 11, 2025

Ikena Oncology (NASDAQ:IKNA) Stock Price Down 0.7%Here's Why - MarketBeat

Feb 11, 2025
pulisher
Feb 10, 2025

A History of Outperforming Analyst Forecasts and Beating the Odds: Ikena Oncology Inc (IKNA) - SETE News

Feb 10, 2025
pulisher
Feb 10, 2025

Understanding the Risks of Investing in Ikena Oncology Inc (IKNA) - Knox Daily

Feb 10, 2025
pulisher
Jan 30, 2025

Ikena Oncology Merger with Inmagene Biopharmaceuticals and Private Placement Financing - Leerink Partners

Jan 30, 2025
pulisher
Jan 16, 2025

Jane Street Group LLC Sells 18,570 Shares of Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World

Jan 16, 2025
pulisher
Jan 13, 2025

Geode Capital Management LLC Acquires 14,319 Shares of Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World

Jan 13, 2025
pulisher
Jan 08, 2025

How former leaders of a sold-off biotech company landed their drugs again - The Business Journals

Jan 08, 2025
pulisher
Jan 03, 2025

Deal Watch: Regeneron Quietly Acquires UK Ophthalmology Firm Oxular - Scrip

Jan 03, 2025
pulisher
Jan 02, 2025

US Penny Stocks To Watch In January 2025 - Simply Wall St

Jan 02, 2025
pulisher
Dec 31, 2024

Ikena Oncology (IKNA) Moves to Buy: Rationale Behind the Upgrade - MSN

Dec 31, 2024
pulisher
Dec 31, 2024

Ikena Oncology and Inmagene Biopharmaceuticals to Merger - citybiz

Dec 31, 2024
pulisher
Dec 27, 2024

Inmagene takes back-door route to Nasdaq listing - The Pharma Letter

Dec 27, 2024
pulisher
Dec 26, 2024

Ikena Oncology, Inc. announced that it expects to receive $75 million in funding from a group of investors - Marketscreener.com

Dec 26, 2024
pulisher
Dec 26, 2024

Five things you need to know, and a Chrismukkah throwback - The Business Journals

Dec 26, 2024
pulisher
Dec 25, 2024

Ikena Oncology, Inc. (NASDAQ:IKNA) Shares Purchased by Fmr LLC - Defense World

Dec 25, 2024
pulisher
Dec 25, 2024

Ikena Oncology Enters into Merger Agreement with Inmagene BiopharmaceuticalsOn December 23, 2024, Ikena Oncology, Inc. (NASDAQ: IKNA) announced a significant development as it entered into a Merger Agreement with Inmagene Biopharmaceuticals. - Defense World

Dec 25, 2024
pulisher
Dec 24, 2024

Boston biotech opts for reverse merger with San Diego company - The Business Journals

Dec 24, 2024
pulisher
Dec 23, 2024

Ikena Oncology Shares Rise After Merger Announcement With Inmagene Biopharmaceuticals - MarketWatch

Dec 23, 2024
pulisher
Dec 23, 2024

Ikena Oncology and Inmagene Biopharmaceuticals announces merger - MSN

Dec 23, 2024
pulisher
Dec 23, 2024

Ikena, after tough year of layoffs, merges with Inmagene to focus on phase 2 dermatitis prospect - Fierce Biotech

Dec 23, 2024
pulisher
Nov 13, 2024

3 US Penny Stocks With Market Caps Over $40M To Consider - Yahoo Finance

Nov 13, 2024
pulisher
Nov 09, 2024

Ikena Oncology Third Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.40 loss in 3Q 2023) - Yahoo Finance

Nov 09, 2024
pulisher
Nov 07, 2024

Ikena Oncology Reports Third Quarter 2024 Financial Results - GlobeNewswire

Nov 07, 2024
pulisher
Aug 18, 2024

On Ikena Oncology ($IKNA) Setting up a Sale - substack.com

Aug 18, 2024

Finanzdaten der Ikena Oncology Inc-Aktie (IKNA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):